Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...
News-Medical.Net on MSN
MD Anderson and SOPHiA GENETICS join forces to accelerate data-driven cancer care
The University of Texas MD Anderson Cancer Center and SOPHiA GENETICS today announced a strategic collaboration that unites ...
Life sciences and diagnostics company Revvity has had a busy couple of years, playing a major role in the next-generation sequencing-based screening of newborns to better enable healthcare ...
Compared to two to three days using conventional methods, test results at the Direct Relief Center of Excellence for ...
Factorial Biotechnologies, a leader in next-generation single-cell sequencing solutions, and Honeycomb Biotechnologies, a pioneer in instrument-free single-cell analysis, today announced a strategic ...
A streamlined, automated process helps scientists coordinate site-ready production-level whole genome sequencing results.
Healthcare Asia Magazine on MSN
Next-generation sequencing services market to reach $8.77b by 2030
The growing use of precision medicine and genomics drives the sector. The global next-generation sequencing services market ...
Located on the Buffalo Niagara Medical Campus and the first next-generation sequencing service provider in the region, UB's Genomics and Bioinformatics Core Facility provides high-quality services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback